Autoantibodies in cord blood of offspring from women with rheumatoid arthritis? A pilot study to investigate placental transfer of autoantibodies in women with RA

Autoantibodies in cord blood of offspring from women with rheumatoid arthritis? A pilot study to investigate placental transfer of autoantibodies in women with RA - RA autoantibodies in cord blood

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

NL-OMON

Registry ID

NL-OMON38801

Enrollment

Registered

2013-12-11

Start date

2014-02-18

Completion date

Unknown

Last updated

2024-04-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

rheumatism rheumatoid arthritis

Interventions

None listed

Eligibility

Age

18 Years to 99 Years

Inclusion criteria

Inclusion criteria: pregnant women with RA diagnosed according to the revised EULAR/ACR 2010 criteria or the 1987 ACR criteria

Exclusion criteria

Exclusion criteria: women under 18 years of age are not eligible to participate for ethical reasons

Design outcomes

Primary

Measure	Time frame
The study design is observational with the primary endpoint: presence/absence and characteristics of autoantibodies in maternal blood and cord blood. Autoantibody-negative women will serve as a negative control.	—

Secondary

Measure	Time frame
Characteristics of autoantibodies in RA	—

Countries

Netherlands

Outcome results